Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Field

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
British Journal of Nursing (Mark Allen Publishing)|October 6, 2017
A strategy for formulating regulation on CSTDsAllison Field, Gemma Hughes, Sarah Rowland
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 4, 2022
Rituximab-pvvr is not an independent predictor for infusion reactions in a cohort given rituximab-pvvr or rituximab: A single-center retrospective studyKatherine Triesel, Robert Seabury, Christopher Miller, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
British Journal of Nursing (Mark Allen Publishing)|October 6, 2017
A strategy for formulating regulation on CSTDsAllison Field, Gemma Hughes, Sarah Rowland
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 4, 2022
Rituximab-pvvr is not an independent predictor for infusion reactions in a cohort given rituximab-pvvr or rituximab: A single-center retrospective studyKatherine Triesel, Robert Seabury, Christopher Miller, et al.
Pageof 1